Jing Liu1,2, Maria Clarissa Tio3, Ashish Verma3, Insa M Schmidt2,3, Titilayo O Ilori2, Felix Knauf4, Finnian R Mc Causland3, Sushrut S Waikar2. 1. Renal Division, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China. 2. Section of Nephrology, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA. 3. Renal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. 4. Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
Abstract
CONTEXT: Abnormalities in calcium metabolism are common in chronic kidney disease (CKD). Diminished urinary calcium excretion may promote vascular calcification and increased urinary calcium excretion may lead to nephrolithiasis and nephrocalcinosis, conditions associated with CKD. OBJECTIVE: To study predictors of urinary calcium excretion and its association with adverse clinical outcomes in CKD. DESIGN, SETTING AND PATIENTS: This study assessed 3768 nondialysis participants in the Chronic Renal Insufficiency Cohort study from April 2003 to September 2008. Participants were followed up to October 2018. EXPOSURE: Clinically plausible predictors of urinary calcium excretion and 24-h urinary calcium excretion at baseline. MAIN OUTCOME MEASURES: Urinary calcium excretion; incident end stage kidney disease (ESKD), CKD progression [50% estimated glomerular filtration rate (eGFR) decline or incident ESKD], all-cause mortality, and atherosclerotic cardiovascular disease events. RESULTS: eGFR was positive correlated with 24-h urinary calcium excretion. The variables most strongly associated with 24-h urinary calcium excretion in males and females were 24-h urinary sodium (β = 0.19 and 0.28, respectively), serum parathyroid hormone (β = -0.22 and -0.20, respectively), loop diuretics (β = 0.36 and 0.26, respectively), thiazide diuretics (β = -0.49 and -0.53, respectively), and self-identified black race (β = -0.23 and -0.27, respectively). Lower urinary calcium excretion was associated with greater risks of adverse outcomes, but these associations were greatly attenuated or nullified after adjustment for baseline eGFR. CONCLUSION: Urinary calcium excretion is markedly lower in individuals with CKD compared to the general population. Determinants of urinary calcium excretion differed between sexes and levels of CKD. Associations between urinary calcium excretion and adverse clinical events were substantially confounded by eGFR.
CONTEXT: Abnormalities in calcium metabolism are common in chronic kidney disease (CKD). Diminished urinary calcium excretion may promote vascular calcification and increased urinary calcium excretion may lead to nephrolithiasis and nephrocalcinosis, conditions associated with CKD. OBJECTIVE: To study predictors of urinary calcium excretion and its association with adverse clinical outcomes in CKD. DESIGN, SETTING AND PATIENTS: This study assessed 3768 nondialysis participants in the Chronic Renal Insufficiency Cohort study from April 2003 to September 2008. Participants were followed up to October 2018. EXPOSURE: Clinically plausible predictors of urinary calcium excretion and 24-h urinary calcium excretion at baseline. MAIN OUTCOME MEASURES: Urinary calcium excretion; incident end stage kidney disease (ESKD), CKD progression [50% estimated glomerular filtration rate (eGFR) decline or incident ESKD], all-cause mortality, and atherosclerotic cardiovascular disease events. RESULTS: eGFR was positive correlated with 24-h urinary calcium excretion. The variables most strongly associated with 24-h urinary calcium excretion in males and females were 24-h urinary sodium (β = 0.19 and 0.28, respectively), serum parathyroid hormone (β = -0.22 and -0.20, respectively), loop diuretics (β = 0.36 and 0.26, respectively), thiazide diuretics (β = -0.49 and -0.53, respectively), and self-identified black race (β = -0.23 and -0.27, respectively). Lower urinary calcium excretion was associated with greater risks of adverse outcomes, but these associations were greatly attenuated or nullified after adjustment for baseline eGFR. CONCLUSION: Urinary calcium excretion is markedly lower in individuals with CKD compared to the general population. Determinants of urinary calcium excretion differed between sexes and levels of CKD. Associations between urinary calcium excretion and adverse clinical events were substantially confounded by eGFR.
Authors: Usha S Govindarajulu; Elizabeth J Malloy; Bhaswati Ganguli; Donna Spiegelman; Ellen A Eisen Journal: Int J Biostat Date: 2009-01-07 Impact factor: 0.968
Authors: Jing Chen; Emile R Mohler; Dawei Xie; Michael G Shlipak; Raymond R Townsend; Lawrence J Appel; Dominic S Raj; Akinlolu O Ojo; Martin J Schreiber; Louise F Strauss; Xiaoming Zhang; Xin Wang; Jiang He; L Lee Hamm Journal: Am J Cardiol Date: 2012-03-31 Impact factor: 2.778
Authors: Jack W Coburn; Hla M Maung; Logan Elangovan; Michael J Germain; Jill S Lindberg; Stuart M Sprague; Mark E Williams; Charles W Bishop Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860
Authors: Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright Journal: J Am Soc Nephrol Date: 2003-07 Impact factor: 10.121
Authors: Wei Yang; Dawei Xie; Amanda H Anderson; Marshall M Joffe; Tom Greene; Valerie Teal; Chi-yuan Hsu; Jeffrey C Fink; Jiang He; James P Lash; Akinlolu Ojo; Mahboob Rahman; Lisa Nessel; John W Kusek; Harold I Feldman Journal: Am J Kidney Dis Date: 2013-10-30 Impact factor: 8.860
Authors: Jacob M Taylor; Lyanne M Kieneker; Martin H de Borst; Sipke T Visser; Ido P Kema; Stephan J L Bakker; Ron T Gansevoort Journal: Kidney Int Rep Date: 2016-12-31
Authors: Kathleen M Hill; Berdine R Martin; Meryl E Wastney; George P McCabe; Sharon M Moe; Connie M Weaver; Munro Peacock Journal: Kidney Int Date: 2012-12-19 Impact factor: 10.612